National Guard Health Affairs – Trademark Portfolio

Entity Type: 99

National Guard Health Affairs holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. The owner is based in Riyadh.

King Abdulaziz Medical City

P.O. Box 22490, Mail Code 1515

Riyadh 11426 , SA

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

National Guard Health Affairs's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does National Guard Health Affairs have?

National Guard Health Affairs has 2 U.S. trademarks filed with the USPTO.

What trademark classes does National Guard Health Affairs file in?

National Guard Health Affairs files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus). Class 35 covers advertising; business management; business administration; office functions.

What is National Guard Health Affairs's trademark registration success rate?

National Guard Health Affairs has a 0% trademark registration rate, with 0 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.